Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic β-cells

Diabetes

Volumn 53, Issue 8, 2004, Pages 2024-2033

  Zhang, You Qing ^a   Cleary, Mary Malo ^a   Si, Yingjie ^a   Liu, Guoxun ^a   Eto, Yuzuru ^b   Kritzik, Marcie ^a   Dabernat, Sandrine ^a   Kayali, Ayse G ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL REGENERATION; CELL SURVIVAL; ENDODERM; EPITHELIUM CELL; GROWTH REGULATION; HOMEOSTASIS; MOUSE; NONHUMAN; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PREGNANCY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STEM CELL;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; EPITHELIAL CELLS; FOLLISTATIN; HUMANS; INTERFERON TYPE II; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PANCREAS; RECOMBINANT PROTEINS;

EID: 3242765289     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.8.2024     Document Type: Article

References (44)

1. Green JB, Smith JC: Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate. Nature 347:391-394, 1990
2. Hemmati-Brivanlou A, Melton DA: Inhibition of activin receptor signaling promotes neuralization in Xenopus. Cell 77:273-281, 1994
3. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14:627-644, 2000
4. Manova K, De Leon V, Angeles M, Kalantry S, Giarre M, Attisano L, Wrana J, Bachvarova RF: mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos. Mech Dev 49:3-11, 1995
5. Furukawa M, Eto Y, Kojima I: Expression of immunoreactive activin A in fetal rat pancreas. Endocr J 42:63-68, 1995
6. Maldonado TS, Kadison AS, Crisera CA, Grau JB, Alkasab SL, Longaker MT, Gittes GK: Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J Gastrointest Surg 4:269-275, 2000
7. Shiozaki S, Tajima T, Zhang YQ, Furukawa M, Nakazato Y, Kojima I: Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim Biophys Acta 1450:1-11, 1999
8. Yamaoka T, Idehara C, Yano M, Matsushita T, Yamada T, Ii S, Moritani M, Hata J, Sugino H, Noji S, Itakura M: Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 102:294-301, 1998
9. Kim SK, Hebrok M, Li E, Oh SP, Schrewe H, Harmon EB, Lee JS, Melton DA: Activin receptor patterning of foregut organogenesis. Genes Dev 14:1866-1871, 2000
10. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H: Activin-binding protein from rat ovary is follistatin. Science 247:836-838, 1990
11. Shimasaki S, Koga M, Esch F, Mercado M, Cooksey K, Koba A, Ling N: Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing. Biochem Biophys Res Commun 152:717-723, 1988
12. Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M: Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 112:575-587, 2003
13. Gray PC, Harrison CA, Vale W: Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci U S A 100:5193-5198, 2003
14. ten Dijke P, Miyazono K, Heldin CH: Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci 25:64-70, 2000
15. Sarvetnick NE, Gu D: Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice. Adv Exp Med Biol 321:85-89, 1992 [discussion in Adv Exp Med Biol 321:91-93, 1992]
16. Sarvetnick NE, Gu D: Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice. Adv Exp Med Biol 321:85-89, 1992 [discussion in Adv Exp Med Biol 321:91-93, 1992]
17. Gu D, Sarvetnick N: Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 118:33-46, 1993
18. Gu D, Lee MS, Krahl T, Sarvetnick N: Transitional cells in the regenerating pancreas. Development 120:1873-1881, 1994
19. Zhang YQ, Zhang H, Maeshima A, Kurihara H, Miyagawa J, Takeuchi T, Kojima I: Up-regulation of the expression of activins in the pancreatic duct by reduction of the beta-cell mass. Endocrinology 143:3540-3547, 2002
20. Bilezikjian LM, Corrigan AZ, Blount AL, Vale WW: Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. Endocrinology 137:4277-4284, 1996
21. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995, 1996
22. Kayali AG, Van Gunst K, Campbell IL, Stotland A, Kritzik M, Liu G, Flodstrom-Tullberg M, Zhang YQ, Sarvetnick N: The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163:859-869, 2003
23. Miralles F, Czernichow P, Scharfmann R: Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 125:1017-1024, 1998
24. Zhang YQ, Kanzaki M, Mashima H, Mine T, Kojima I: Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes. Hepatology 23:288-293, 1996
25. Kogure K, Zhang YQ, Maeshima A, Suzuki K, Kuwano H, Kojima I: The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology 31:916-921, 2000
26. Sehy DW, Shao LE, Yu AL, Tsai WM, Yu J: Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase. J Cell Biochem 50:255-265, 1992
27. Gamer LW, Wolfman NM, Celeste AJ, Hattersley G, Hewick R, Rosen V: A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol 208:222-232, 1999
28. Penny C, Kramer B: Exogenous activin increases the proportion of insulin cells in the developing chick pancreas in culture. Cell Biol Int 26:1057-1064, 2002
29. Demeterco C, Beattie GM, Dib SA, Lopez AD, Hayek A: A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab 85:3892-3897, 2000
30. Zhang YQ, Sarvetnick N: Development of cell markers for the identification and expansion of islet progenitor cells. Diabetes Metab Res Rev 19:363-374, 2003
31. Yasuda H, Tanaka S, Ohnishi H, Mashima H, Ogushi N, Mine T, Kojima I: Activin A: negative regulator of amylase secretion and cell proliferation in rat pancreatic acinar AR42J cells. Am J Physiol 267:G220-G226, 1994
32. Hempen PM, Zhang L, Bansal RK, Iacobuzio-Donahue CA, Murphy KM, Maitra A, Vogelstein B, Whitehead RH, Markowitz SD, Willson JK, Yeo CJ, Hruban RH, Kern SE: Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res 63:994-999, 2003
33. Furukawa M, Zhang YQ, Nie L, Shibata H, Kojima I: Role of mitogen-activated protein kinase and phosphoinositide 3-kinase in the differentiation of rat pancreatic AR42J cells induced by hepatocyte growth factor. Diabetologia 42:450-456, 1999
34. Ogihara T, Watada H, Kanno R, Ikeda F, Nomiyama T, Tanaka Y, Nakao A, German MS, Kojima I, Kawamori R: p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells. J Biol Chem 278:21693-21700, 2003
35. Zhang YQ, Kanzaki M, Furukawa M, Shibata H, Ozeki M, Kojima I: Involvement of Smad proteins in the differentiation of pancreatic AR42J cells induced by activin A. Diabetologia 42:719-727, 1999
36. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK: Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 99:16105-16110, 2002
37. Ciardiello F, Dono R, Kim N, Persico MG, Salomon DS: Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res 51:1051-1054, 1991
38. Adamson ED, Minchiotti G, Salomon DS: Cripto: a tumor growth factor and more. J Cell Physiol 190:267-278, 2002
39. Tsutsumi M, Yasui W, Naito A, Ohashi K, Kobayashi E, Noguchi O, Horiguchi K, Okita S, Tsujiuchi T, Kitada H, Ishikawa O, Tahara E, Konishi Y: Expression of cripto in human pancreatic tumors. Jpn J Cancer Res 85:118-121, 1994
40. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N: Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A 95:9337-9342, 1998
41. Zhang YQ, Mashima H, Kanzaki M, Shibata H, Kojima I: Assessment of the role of activin A and transforming growth factor beta in the regulation of AML12 cell growth. Hepatology 25:1370-1375, 1997
42. Florio P, Luisi S, Marchetti P, Lupi R, Cobellis L, Falaschi C, Sugino H, Navalesi R, Genazzani AR, Petraglia F: Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Invest 23:231-234, 2000
43. Furukawa M, Nobusawa R, Shibata H, Eto Y, Kojima I: Initiation of insulin secretion in glucose-free medium by activin A. Mol Cell Endocrinol 113:83-87, 1995
44. Totsuka Y, Tabuchi M, Kojima I, Shibai H, Ogata E: A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem Biophys Res Commun 156:335-339, 1988